S&P 500   3,851.85
DOW   31,188.38
QQQ   323.77
pixel
pixel
pixel
S&P 500   3,851.85
DOW   31,188.38
QQQ   323.77
pixel
pixel
pixel
S&P 500   3,851.85
DOW   31,188.38
QQQ   323.77
pixel
pixel
pixel
S&P 500   3,851.85
DOW   31,188.38
QQQ   323.77
pixel
pixel
pixel
Log in
NASDAQ:AFIB

Acutus Medical Stock Forecast, Price & News

$25.69
+2.06 (+8.72 %)
(As of 01/20/2021 12:00 AM ET)
Add
Compare
Today's Range
$23.52
Now: $25.69
$26.30
50-Day Range
$23.63
MA: $29.43
$34.00
52-Week Range
$22.26
Now: $25.69
$38.99
Volume609,660 shs
Average Volume404,434 shs
Market Capitalization$715.36 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. It offers AcQMap console and workstation, an advanced imaging, navigation, and mapping system for physicians to map, treat, re-map, and adjust additional therapy as needed; and Patient Electrode Kit that is required in every procedure to provide cardiac signals, catheter localization, and AcQMap system grounding. The company also provides diagnostic and monitoring devices, such as AcQMap 3D Imaging and Mapping Catheter that is used for mapping during the electrophysiology procedures; conventional diagnostic catheters, including multi-polar, steerable, and loop catheters that are used during the mapping and ablation procedures; and reprocessed diagnostic catheters, such as diagnostic, multipole, fixed, steerable, and advanced mapping and imaging catheters. In addition, the company provides access devices, which include AcQRef Introducer that provides stable electrical reference and vascular access; AcQGuide MAX Steerable Introducer, which provides a stable platform for catheter passage and precision placement; and Transseptal Access Products. Further, it offers therapeutic devices, such as AcQBlate FORCE Ablation Catheters, AlCath Ablation Catheters, MedFact Robotic Navigation Enabled Ablation Catheters, Qubic Force, Qubic RF Generator and Pulse Stimulator, and Qiona Pump. The company also provides various software mapping modes comprises single position, supermap, contact mapping, and stereotaxis integration. Acutus Medical, Inc. was founded in 2011 and is based in Carlsbad, California.

MarketRank

Overall MarketRank

1.52 out of 5 stars

Medical Sector

399th out of 1,928 stocks

Surgical & Medical Instruments Industry

36th out of 170 stocks

Analyst Opinion: 3.3Community Rank: 2.0Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:AFIB
CUSIPN/A
CIKN/A
Phone442-232-6080
Employees224

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.84 million

Profitability

Net Income$-97,040,000.00
Net Margins-1,410.17%

Miscellaneous

Market Cap$715.36 million
Next Earnings Date2/11/2021 (Estimated)
OptionableNot Optionable
$25.69
+2.06 (+8.72 %)
(As of 01/20/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive AFIB News and Ratings via Email

Sign-up to receive the latest news and ratings for AFIB and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Acutus Medical (NASDAQ:AFIB) Frequently Asked Questions

Is Acutus Medical a buy right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Acutus Medical in the last twelve months. There are currently 2 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Acutus Medical stock.
View analyst ratings for Acutus Medical
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Acutus Medical?

Wall Street analysts have given Acutus Medical a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Acutus Medical wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

What is Doug Parker's approval rating as Acutus Medical's CEO?

1,428 employees have rated Acutus Medical CEO Doug Parker on Glassdoor.com. Doug Parker has an approval rating of 59% among Acutus Medical's employees. This puts Doug Parker in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

When is Acutus Medical's next earnings date?

Acutus Medical is scheduled to release its next quarterly earnings announcement on Thursday, February 11th 2021.
View our earnings forecast for Acutus Medical
.

How were Acutus Medical's earnings last quarter?

Acutus Medical, Inc. (NASDAQ:AFIB) issued its earnings results on Tuesday, November, 17th. The company reported ($1.95) EPS for the quarter, missing the consensus estimate of ($1.11) by $0.84. The business earned $3.17 million during the quarter, compared to analyst estimates of $3.03 million.
View Acutus Medical's earnings history
.

What guidance has Acutus Medical issued on next quarter's earnings?

Acutus Medical updated its fourth quarter 2020 Pre-Market earnings guidance on Wednesday, January, 13th. The company provided EPS guidance of for the period. The company issued revenue guidance of $2.4-2.6 million, compared to the consensus revenue estimate of $5.05 million.

What price target have analysts set for AFIB?

5 Wall Street analysts have issued 1-year price objectives for Acutus Medical's stock. Their forecasts range from $30.00 to $40.00. On average, they anticipate Acutus Medical's stock price to reach $34.75 in the next twelve months. This suggests a possible upside of 35.3% from the stock's current price.
View analysts' price targets for Acutus Medical
or view Wall Street analyst' top-rated stocks.

Who are some of Acutus Medical's key competitors?

What other stocks do shareholders of Acutus Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Acutus Medical investors own include Oak Street Health (OSH), Alibaba Group (BABA), Checkmate Pharmaceuticals (CMPI), salesforce.com (CRM), The Walt Disney (DIS), DocuSign (DOCU), Marvell Technology Group (MRVL), NVIDIA (NVDA), Tesla (TSLA) and Twilio (TWLO).

Who are Acutus Medical's key executives?

Acutus Medical's management team includes the following people:
  • Mr. R. Scott Huennekens M.B.A., CPA, Exec. Chairman (Age 56, Pay $286k)
  • Mr. Vincent J. Burgess, Pres, CEO & Director (Age 55, Pay $532.32k)
  • Mr. Gary W. Doherty, Chief Financial Officer (Age 54, Pay $365.9k)
  • Mr. Steven P. McQuillan, Sr. VP of Regulatory & Clinical Affairs (Age 58, Pay $402.13k)
  • Mr. Richard M. Kimes, Sr. VP of Operations (Age 58)
  • Dr. Graydon E. Beatty, Chief Technology Officer (Age 63)
  • Mr. Tom Sohn, Sr. VP, Gen. Counsel & Sec. (Age 45)
  • Mr. Charlie Piscitello, Chief People Officer (Age 57)
  • Mr. Peter Elia, Chief Strategy & Bus. Devel. Officer (Age 49)
  • Mr. John Barnickel, Chief Commercial Officer (Age 52)

When did Acutus Medical IPO?

(AFIB) raised $126 million in an initial public offering (IPO) on Thursday, August 6th 2020. The company issued 7,400,000 shares at $16.00-$18.00 per share. J.P. Morgan, BofA Securities and William Blair acted as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.

What is Acutus Medical's stock symbol?

Acutus Medical trades on the NASDAQ under the ticker symbol "AFIB."

When does the company's lock-up period expire?

Acutus Medical's lock-up period expires on Tuesday, February 2nd. Acutus Medical had issued 8,823,529 shares in its initial public offering on August 6th. The total size of the offering was $158,823,522 based on an initial share price of $18.00. After the expiration of the company's lock-up period, restrictions preventing major shareholders and company insiders from selling shares in the company will be lifted.

Who are Acutus Medical's major shareholders?

Acutus Medical's stock is owned by many different retail and institutional investors. Top institutional investors include Westside Investment Management Inc. (0.05%).

Which major investors are buying Acutus Medical stock?

AFIB stock was acquired by a variety of institutional investors in the last quarter, including Westside Investment Management Inc..

How do I buy shares of Acutus Medical?

Shares of AFIB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Acutus Medical's stock price today?

One share of AFIB stock can currently be purchased for approximately $25.69.

How big of a company is Acutus Medical?

Acutus Medical has a market capitalization of $715.36 million and generates $2.84 million in revenue each year. Acutus Medical employs 224 workers across the globe.

What is Acutus Medical's official website?

The official website for Acutus Medical is www.acutusmedical.com.

How can I contact Acutus Medical?

Acutus Medical's mailing address is 2210 FARADAY AVE SUITE 100, CARLSBAD CA, 92008. The company can be reached via phone at 442-232-6080 or via email at [email protected]

This page was last updated on 1/21/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.